Robocath’s R-One robotic platform has been used to successfully complete the first five robotic coronary angioplasties in Belgium.
Royal Philips and Elekta have signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions.
Neurescue, a Copenhagen, Denmark-based medical device company developing cardiovascular solutions, has received U.S. FDA clearance to market the company’s NEURESCUE device for temporary occlusion of large vessels, including patients requiring emergency control of haemorrhage.
The first-in-human use of Foldax’s biopolymer Tria™ heart valve as a replacement for a diseased mitral valve has shown positive results. The first case was performed by David Heimansohn, MD, at Ascension St. Vincent Hospital, Indianapolis, as part of a U.S. early feasibility research study.
A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumours. Their findings, published in the journal ACS Applied Materials & Interfaces, have indicated that regular urine tests could help early detection and treatment of brain tumours, possibly leading to improved patient survival.
Procyrion, a medical device company developing catheter-deployed pump technology, has successfully treated the first patients in the company’s pilot trial to evaluate the performance of its novel Aortix™ percutaneous mechanical circulatory support (pMCS) device in patients with cardiorenal syndrome (CRS). The company began its pilot trial in Australia and recently expanded to the U.S. after […]
Carestream Health is transforming and accelerating the way it develops and delivers AI applications for medical imaging that help improve patient care.
Owlstone Medical (OML), the global leader in breath biopsy for applications in early disease detection and precision medicine, has reached agreements with Functional Gut Clinic (FGC) and Functional Gut Diagnostics (FGD), leading providers of smart solutions for the diagnosis of gut health problems.
The International Hospital Federation (IHF) is launching its 2021 IHF Awards, its premier awards program for hospitals and health service providers after its postponement in 2020 due to the pandemic.
The VAX TRUST consortium was recently established with the aim of addressing vaccine hesitancy in Europe and to help healthcare professionals prepare for meeting with vaccine hesitant individuals. International Hospital speaks to Pia Vuolanto, the head of consortium, about VAX TRUST and the issue of vaccine hesitancy.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
